O
OrbiMed Portfolio holdings
AUM
$3.98B
This Quarter Return
+7.57%
1 Year Return
+13.05%
3 Year Return
+159.74%
5 Year Return
+207.27%
10 Year Return
+1,027.33%
AUM
$4.43B
AUM Growth
–
Cap. Flow
+$4.4B
Cap. Flow
% of AUM
99.27%
Top 10 Holdings %
Top 10 Hldgs %
40.13%
Holding
117
New
107
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Amgen
AMGN
|
$258M |
| 2 |
Gilead Sciences
GILD
|
$247M |
| 3 |
Biogen
BIIB
|
$221M |
| 4 |
Merck
MRK
|
$192M |
| 5 |
Viatris
VTRS
|
$155M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 85.21% |
| 2 | Financials | 2.18% |
| 3 | Technology | 0.15% |
| 4 | Utilities | 0.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
MDVN
26
DELISTED
MEDIVATION, INC.
MDVN
| $72.4M | 1.54% |
+1,472,100
| New | +$72.4M |
|
27
Exact Sciences
EXAS
$9.33B
| $65.4M | 1.39% |
+4,701,900
| New | +$65.4M |
|
|
IPXL
28
DELISTED
Impax Laboratories, Inc.
IPXL
| $65M | 1.38% |
+3,260,600
| New | +$65M |
|
29
Molina Healthcare
MOH
$9.6B
| $61.9M | 1.31% |
+1,665,000
| New | +$61.9M |
|
|
WCRX
30
DELISTED
WARNER CHILCOTT PLC ORD SHS CL A (IRL)
WCRX
| $54.8M | 1.16% |
+2,753,100
| New | +$54.8M |
|
|
NXTM
31
DELISTED
NxStage Medical Inc.
NXTM
| $46M | 0.98% |
+3,221,100
| New | +$46M |
|
|
ATRS
32
DELISTED
Antares Pharma, Inc.
ATRS
| $38.3M | 0.81% |
+9,199,000
| New | +$38.3M |
|
33
Cigna
CI
$80.2B
| $31M | 0.66% |
+427,000
| New | +$31M |
|
34
Align Technology
ALGN
$9.59B
| $30.5M | 0.65% |
+824,000
| New | +$30.5M |
|
|
AFFX
35
DELISTED
AFFYMETRIX INC
AFFX
| $28.3M | 0.6% |
+6,375,400
| New | +$28.3M |
|
|
MAKO
36
DELISTED
MAKO SURGICAL CORP COM
MAKO
| $26.7M | 0.57% |
+2,212,100
| New | +$26.7M |
|
|
AGN
37
DELISTED
ALLERGAN INC
AGN
| $25.4M | 0.54% |
+302,000
| New | +$25.4M |
|
38
Acadia Pharmaceuticals
ACAD
$4.34B
| $23.5M | 0.5% |
+1,293,000
| New | +$23.5M |
|
|
ARRY
39
DELISTED
Array Biopharma Inc
ARRY
| $22.1M | 0.47% |
+4,865,000
| New | +$22.1M |
|
40
Standard BioTools
LAB
$493M
| $22M | 0.47% |
+1,262,708
| New | +$22M |
|
41
Centene
CNC
$14.8B
| $21.9M | 0.47% |
+418,300
| New | +$21.9M |
|
|
HNT
42
DELISTED
HEALTH NET INC
HNT
| $20.7M | 0.44% |
+650,000
| New | +$20.7M |
|
|
XNPT
43
DELISTED
XENOPORT, INC.
XNPT
| $20M | 0.42% |
+4,040,800
| New | +$20M |
|
|
NTUS
44
DELISTED
Natus Medical Inc
NTUS
| $19.5M | 0.41% |
+1,427,000
| New | +$19.5M |
|
45
IQVIA
IQV
$31.4B
| $18.7M | 0.4% |
+440,000
| New | +$18.7M |
|
46
OraSure Technologies
OSUR
$230M
| $18.5M | 0.39% |
+4,760,300
| New | +$18.5M |
|
47
Vertex Pharmaceuticals
VRTX
$102B
| $17.9M | 0.38% |
+223,000
| New | +$17.9M |
|
|
ALXN
48
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $17.8M | 0.38% |
+192,900
| New | +$17.8M |
|
49
Johnson & Johnson
JNJ
$429B
| $17.3M | 0.37% |
+201,000
| New | +$17.3M |
|
|
DNDN
50
DELISTED
DENDREON CORPORATION
DNDN
| $16.9M | 0.36% |
+4,102,300
| New | +$16.9M |
|